Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Coherus Oncology Inc. June 11, 202571.3%
-
BridgeBio Pharma Inc. June 21, 202474.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Jun 5, 2026 | Coherus Oncology Inc. | Grant or award | +30,000 | — | — |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| Dec 30, 2024 | BridgeBio Pharma Inc. | Option exercise | +79,702 | $10.99 | $875,925 |
| Dec 30, 2024 | BridgeBio Pharma Inc. | Option exercise | +39,851 | $16.68 | $664,715 |
| Dec 30, 2024 | BridgeBio Pharma Inc. | Option exercise | +39,851 | $26.21 | $1,044,495 |
Questions about Ali J. Satvat
What boards is Ali J. Satvat on?
Ali J. Satvat sits on the boards of BridgeBio Pharma Inc. and Coherus Oncology Inc.
How long has Ali J. Satvat served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.